Search

Displaying results 6581 - 6590 of 8696 in total
  1. Drug

    Petrelintide

    go.drugbank.com/drugs/DB19442
    Investigational

    Petrelintide is under investigation in clinical trial NCT06662539 (Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities).

  2. Drug

    Hetrombopag

    go.drugbank.com/drugs/DB16184
    Investigational

    Hetrombopag is under investigation in clinical trial NCT03976882 (Hetrombopag for the Treatment of Chemotherapy-induced Thrombocytopenia in Subjects With Malignancy.).

  3. Drug

    Acteoside

    go.drugbank.com/drugs/DB12996
    Investigational

    Acteoside is under investigation in clinical trial NCT02662283 (Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy).

  4. Drug

    Nevanimibe

    go.drugbank.com/drugs/DB16254
    Investigational

    Nevanimibe is under investigation in clinical trial NCT03053271 (A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome).

  5. Drug

    Biomed 101

    go.drugbank.com/drugs/DB05851
    Investigational

    Biomed 101 is investigated for use/treatment in adverse effects (chemotherapy) and renal cell carcinoma. Biomed 101 is a solid. … Biomed 101 binds to the leukotriene B4 receptor, but does not affect interleukin-2 antitumor activity.

  6. Drug

    Phenothiazine

    go.drugbank.com/drugs/DB11447
    ExperimentalVet approved

    Phenothiazine (PTZ) is an organic thiazine compound.

  7. Drug

    Rimazolium

    go.drugbank.com/drugs/DB13289
    Experimental

    Rimazolium is an experimental analgesic drug [A176186].

  8. Drug

    Diphenyleneiodonium

    go.drugbank.com/drugs/DB17025
    Experimental

    An NADPH oxidase 2 (NOX2) inhibitor.[A252987]

  9. Drug

    Acecainide

    go.drugbank.com/drugs/DB17602
    Experimental

    Acecainide is an investigational anti-arrhythmia drug.

  10. Drug

    AKI-001

    go.drugbank.com/drugs/DB07266
    Experimental

    AKI-001 is an aurora kinase inhibitor.